Sign In
Buy ASND
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026
Geode Capital Management LLC Increases Position in Ascendis Pharma A/S (NASDAQ:ASND)
09:22am, Monday, 27'th Apr 2020
Geode Capital Management LLC increased its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND) by 0.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exc
Altium Wealth Management LLC Invests $259,000 in Ascendis Pharma A/S (NASDAQ:ASND)
10:42am, Saturday, 25'th Apr 2020
Altium Wealth Management LLC acquired a new stake in Ascendis Pharma A/S (NASDAQ:ASND) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC
SVB Leerink Analysts Reduce Earnings Estimates for Ascendis Pharma A/S (NASDAQ:ASND)
06:06am, Friday, 24'th Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) – Stock analysts at SVB Leerink decreased their Q1 2020 EPS estimates for Ascendis Pharma A/S in a research report issued to clients and investors on Monday, April
Ascendis Pharma A/S (NASDAQ:ASND) PT Raised to $201.00
08:24am, Wednesday, 22'nd Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) had its price target hoisted by equities research analysts at Cantor Fitzgerald from $185.00 to $201.00 in a research report issued on Monday, MarketBeat reports. The
Ascendis Pharma A/S (NASDAQ:ASND) PT Raised to $171.00
07:50am, Wednesday, 22'nd Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) had its target price hoisted by stock analysts at Stifel Nicolaus from $146.00 to $171.00 in a research report issued on Monday, The Fly reports. The brokerage curren
Oppenheimer Boosts Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $219.00
07:50am, Wednesday, 22'nd Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) had its price objective lifted by analysts at Oppenheimer from $199.00 to $219.00 in a report released on Monday, The Fly reports. The firm presently has an “outper
JPMorgan Chase & Co. Increases Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $150.00
07:18am, Wednesday, 22'nd Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) had its price target raised by stock analysts at JPMorgan Chase & Co. from $145.00 to $150.00 in a note issued to investors on Monday, The Fly reports. The firm prese
Biofrontera's New Deal, And Other News: The Good, Bad And Ugly Of Biopharma
05:16am, Wednesday, 22'nd Apr 2020
Biofrontera inks a new deal and announces earnings. Ascendis reports top line data from TransCon trial. Precigen will start a phase 2/3 trial in HPV.
Need To Know: The Consensus Just Cut Its Ascendis Pharma A/S (NASDAQ:ASND) Estimates For 2020
10:12am, Tuesday, 21'st Apr 2020
The latest analyst coverage could presage a bad day for Ascendis Pharma A/S (NASDAQ:ASND), with the analysts making...
Ascendis Pharma A/S (NASDAQ:ASND) Analysts Just Slashed This Year's Revenue Estimates By 12%
10:01am, Tuesday, 21'st Apr 2020
Market forces rained on the parade of Ascendis Pharma A/S (NASDAQ:ASND) shareholders today, when the analysts...
Bank of America Corp DE Decreases Position in Ascendis Pharma A/S (NASDAQ:ASND)
08:54am, Tuesday, 21'st Apr 2020
Bank of America Corp DE lowered its position in Ascendis Pharma A/S (NASDAQ:ASND) by 25.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exch
Ascendis Pharma (ASND) Received its Third Buy in a Row
03:45pm, Monday, 20'th Apr 2020
After Merrill Lynch and Canaccord Genuity gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another Buy, this time from
Ascendis Pharma (ASND) Received its Third Buy in a Row
03:45pm, Monday, 20'th Apr 2020
After Merrill Lynch and Canaccord Genuity gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink ASND;TAK
01:41pm, Monday, 20'th Apr 2020
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink SVB Leerink ASND TAK
Ascendis Pharma price target raised to $150 from $145 at JPMorgan ASND
01:04pm, Monday, 20'th Apr 2020
Ascendis Pharma price target raised to $150 from $145 at JPMorgan JPMorgan ASND
